, for Good Clinical Practice -ICH Harmonised Tripartite Guideline

D. Sur,

A. Bhatt, Evolution of Clinical Research: A History Before and Beyond James Lind, Perspect Clin Res, vol.1, issue.1, pp.6-10, 2010.

R. Kunz, Randomisation to protect against selection bias in healthcare trials, vol.33, 2008.

, WMA -The World Medical Association-Déclaration d'Helsinki de L'AMM -Principes éthiques applicables à la recherche médicale impliquant des êtres humains, The Nuremberg Code [from Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Nuremberg, pp.1949-1953, 1946.

D. Sur,

J. Lefrère, Les bébés du thalidomide, La Presse Médicale. mars, vol.40, issue.3, pp.301-309, 1975.

T. Study--timeline and -. , , 2018.

A. Vijayananthan, Code de la santé publique | Legifrance -Titre II « Recherches impliquant la personne humaine, Biomed Imaging Interv J. 1 janv, vol.4, issue.1, 2008.

D. Sur,

, relative au renforcement de la sécurité sanitaire du médicament et des produits de santé, 2011.

L. Loi-«-informatique, ». Libertés, and . Cnil,

D. Sur,

G. D. Huang, Clinical trials recruitment planning: A proposed framework from the

, Clinical Trials Transformation Initiative. Contemporary Clinical Trials. mars, vol.66, pp.74-83, 2018.

S. Sisodia and S. S. , A Review of New Drug Innovation -Emerging Challenges And Mitigation Strategies, IOSR Journal of Pharmacy (IOSRPHR), vol.04, issue.01, pp.43-51, 2014.

B. Carlisle, Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials, Clinical Trials: Journal of the Society for Clinical Trials. févr, vol.12, issue.1, pp.77-83, 2015.

C. Tufts and . Impact, Clinical trials submitted in marketing-authorisation applications to the European Medicines Agency -Overview of patient recruitment and the geographical location of investigator sites, p.15, 2013.

K. Getz, Industry Practices that Benefit/Will Benefit by Patient Engagement, p.9

A. Editors, Recruitment Strategies: A European Perspective

D. Sur,

C. Warlow, Advanced issues in the design and conduct of randomized clinical trials: the bigger the better? Statistics in Medicine, vol.21, pp.2797-805, 2002.

D. Sur,

L. Martin, How much do clinical trials cost?, Nature Reviews Drug Discovery, vol.16, issue.6, pp.381-383, 2017.

B. Nicolas, La recherche clinique à l'heure du numérique. 2èmes Assises de l'innovation

. Thérapeutique,

D. Sur,

T. Grom, Showcase Feature: Unclogging the Patient Recruitment Bottleneck

. Pharmavoice,

K. A. Getz, Patient-Recruitment-The-Most-Recognized-Silent-Driver-of-Clinical-Development-Costs.pdf 29. A Paradigm Shift in Patient Recruitment for Clinical Trials, Drug Inf J. juill, vol.50, issue.4, pp.436-477, 2016.

D. Sur, Nelaton C. Le consentement pour le respect de l'autonomie du patient: mise en perspective éthico-philosophique. Cours d'éthique médicale, M2 Management des Opérations Cliniques, 2018.

M. E. Falagas, Perceptions and insights study -The participation experience -CISCRP, The American Journal of Surgery. sept, vol.198, issue.3, pp.420-455, 2009.

D. Sur,

A. Samadi, Readability of informed consent forms in clinical trials conducted in a skin research center, J Med Ethics Hist Med. 3 juill, vol.9, 2016.

S. A. Grossman, Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? JCO, vol.12, pp.2211-2216, 1994.

T. Marli, Examining the readability of patient-informed consent forms, Open Access Journal of Clinical Trials, vol.2, 2010.

, Lignes directrices internationales d'éthique pour la recherche biomédicale impliquant des sujets humains

J. M. Watson, Increasing recruitment to randomised trials: a review of randomised controlled trials, BMC Medical Research Methodology. déc, vol.6, issue.1, 2006.

R. B. Gul, Clinical trials: the challenge of recruitment and retention of participants, Journal of Clinical Nursing. janv, vol.19, issue.1-2, pp.227-260, 2010.

S. Treweek, Strategies to improve recruitment to randomised controlled trials

, Cochrane Methodology Review Group, éditeur. Cochrane Database of Systematic Reviews. 14 avr, 2010.

L. C. Lovato, Recruitment for controlled clinical trials: Literature summary and annotated bibliography, Controlled Clinical Trials. août, vol.18, issue.4, pp.328-52, 1997.

E. Mahon, Barriers to Clinical Trial Recruitment and Possible Solutions: A Stakeholder Survey

E. Grunfeld, Barriers and facilitators to enrollment in cancer clinical trials, Cancer, vol.95, issue.7, pp.1577-83, 2002.

S. Sullivan-bolyai, Barriers and Strategies for Recruiting Study Participants in Clinical Settings, Western Journal of Nursing Research. juin, vol.29, issue.4, pp.486-500, 2007.

G. Frank, Current challenges in clinical trial patient recruitment and enrollment. SoCRA SOURCE, 2003.

K. A. Getz, Assessing the Impact of Protocol Design Changes on Clinical Trial Performance, American Journal of Therapeutics. sept, vol.15, issue.5, pp.450-457, 2008.

M. King, Impact of Participant and Physician Intervention Preferences on Randomized Trials: A Systematic Review, JAMA. 2 mars, vol.293, issue.9, 2005.

D. Sur, study-clinical-trial-information-seekers/?wpdmdl=6646 48. Perceptions and Insights Study -Decision-Making Process -CISCRP, 2017.

C. H. Grant, Patients' Perceptions of Physicians Communication and Outcomes of the Accrual to Trial Process, Health Communication. janv, vol.12, issue.1, pp.23-39, 2000.

R. S. Mannel, Impact of Individual Physicians on Enrollment of Patients, Clinical Trials: American Journal of Clinical Oncology. avr, vol.26, issue.2, pp.171-174, 2003.

M. Campbell, Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study. Health Technology Assessment, vol.11, 2007.

C. Tufts and . Impact, , 2017.

S. Djurisic, Barriers to the conduct of randomised clinical trials within all disease areas, Trials. 1 août, vol.18, issue.1, p.360, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01572262

. Scadding-hunt, , vol.9

. Issuu,

D. Sur, Perceptions and insights study : General perceptions -CISCRP, 2013.

D. Sur, studygeneral-perceptions/?wpdmdl=6648 56. Perceptions and insights study -General perceptions and knowledge on clinical research -CISCRP, 2017.

D. Sur,

B. R. Cassileth, Attitudes Toward Clinical Trials Among Patients and the Public, JAMA. 27 août, vol.248, issue.8, pp.968-70, 1982.

C. R. Baquet, Clinical Trials -The Art of Enrollment, Semin Oncol Nurs. nov, vol.24, issue.4, pp.262-271, 2008.

, Lilly Uses Patient Awareness Access To Cut Clinical Trial Timelines

D. Sur,

. Leem, Attractivite des essais cliniques, Dossier consolidé, 2018.

D. Sur, Trends, Charts, and Maps -ClinicalTrials.gov

D. Sur,

B. Brescia, Better Budgeting for Patient Recruitment, 2018.

D. Sur,

R. Collier, Rapidly rising clinical trial costs worry researchers, CMAJ. 3 févr, vol.180, issue.3, pp.277-285, 2009.

C. S. Bennette, Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials, Journal of the National Cancer Institute. févr, vol.108, issue.2, p.324, 2016.

R. La, , p.3, 2008.

J. Fisher-wilson, Health Insurance Portability and Accountability Act Privacy Rule Causes Ongoing Concerns among Clinicians and Researchers, Annals of Internal Medicine. 15 août, vol.145, issue.4, p.313, 2006.

G. Nahler, Dictionary of Pharmaceutical Medicine, Nahler G, éditeur, pp.105-105, 2009.

K. Morin, Managing Conflicts of Interest in the Conduct of Clinical Trials, JAMA. 2 janv, vol.287, issue.1, p.78, 2002.

A. Editors, Physicians' Outlook on Participation

, Working Together to Find Answers: An Example of Patient Advocacy Group Involvement | Rare Diseases Clinical Research Network, Disponible sur, 2018.

D. Sur, Decision tree for optimizing Protocol design [Internet]

D. Sur,

. Eupati, , 2015.

. Fda/cder, Bent R. Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance for Industry, vol.36, 2018.

S. Chow, Adaptive design methods in clinical trials -a review, Orphanet J Rare Dis. 2 mai, vol.3, p.11, 2008.

, Electronic Health Records for Clinical Research -(EHR4CR)

D. Sur, PCORnet, the National Patient-Centered Clinical Research Network

D. Sur,

Y. Henry, Use of an Electronic Health Record to Optimize Site Performance in Randomized Clinical Trials, Journal of Clinical Trials, issue.01, p.5, 2014.

J. Doods, A European inventory of data elements for patient recruitment, Studies in Health Technology and Informatics, pp.506-510, 2015.

, -41 du 26 janvier 2016 de modernisation de notre système de santé, 2016.

M. R. Cowie, Electronic health records to facilitate clinical research, Clinical Research in Cardiology. janv, vol.106, issue.1, pp.1-9, 2017.

S. R. Raman, Leveraging electronic health records for clinical research, American Heart Journal. août, vol.202, pp.13-22, 2018.

, RGPD 2018: espace d'information numérique -règlement européen sur la protection des données, Bioéthique. juin, vol.85, pp.85-94, 2018.

E. Yang, Quantifying and visualizing site performance in clinical trials, Contemporary Clinical Trials Communications. mars, vol.9, pp.108-122, 2018.

R. J. Prescott, Factors that limit the quality, number and progress of randomised controlled trials: a review, Health Technol Assess, vol.3, 1920.

J. Sotelo, Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal, PLoS Medicine. 11 juill, vol.3, issue.7, p.306, 2006.

F. A. Thiers, Trends in the globalization of clinical trials, Nature Reviews Drug Discovery. 1 janv, vol.7, pp.13-17, 2008.

, High costs and recruitment issues drive the globalization of clinical trials, p.4

R. Singh, Clinical trials in "emerging markets": Regulatory considerations and other factors, Contemporary Clinical Trials, vol.36, issue.2, pp.711-719, 2013.

A. T. Schroen, Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials, Clin Trials. août, vol.7, issue.4, pp.312-333, 2010.

A. Thoma, How to optimize patient recruitment, Can J Surg. juin, vol.53, issue.3, pp.205-215, 2010.

V. S. Effoe, The use of electronic medical records for recruitment in clinical trials: findings from the Lifestyle Intervention for Treatment of Diabetes trial, Trials. déc, vol.17, issue.1, p.496, 2016.

F. Köpcke, Secondary use of routinely collected patient data in a clinical trial: an evaluation of the effects on patient recruitment and data acquisition, Int J Med Inform. mars, vol.82, issue.3, pp.185-92, 2013.

S. R. Thadani, Electronic Screening Improves Efficiency in Clinical Trial Recruitment, Journal of the American Medical Informatics Association, vol.16, issue.6, pp.869-73, 2009.

E. Sumi, The correlation between the number of eligible patients in routine clinical practice and the low recruitment level in clinical trials: a retrospective study using electronic medical records, Trials. 11 déc, vol.14, issue.1, p.426, 2013.

J. Spencer, Utilizing Electronic Medical Record Networks For Identifying Patients For Clinical Trial Recruitment, A18. 99. Perceptions and Insights Study -Decision-Making Process -CISCRP, vol.18, 2015.

M. Dugas, Routine data from hospital information systems can support patient recruitment for clinical studies, Clinical Trials: Journal of the Society for Clinical Trials. avr, vol.7, issue.2, pp.183-192, 2010.

L. Meloni, Towards the next level of recruitment -3rd Insite User Meeting, 2019.

T. Caulfield, Legal and Ethical Issues Associated with Patient Recruitment in Clinical Trials: The Case of Competitive Enrolment, Health Law Review, vol.13, issue.2, p.4

T. Reynolds, Clinical trials: can technology solve the problem of low recruitment?, BMJ. 14 juin, vol.342, issue.2, pp.3662-3662, 2011.

A. Hapca, Effectiveness of newspaper advertising for patient recruitment into a clinical trial: Advertising for trial recruitment, British Journal of Clinical Pharmacology. juin, vol.77, issue.6, pp.1064-72, 2014.

A. D. Smith, E-recruitment of patients for clinical trials, International Journal of Electronic Healthcare, vol.1, issue.4, p.413, 2005.

L. J. Burgess, The role of print advertising in clinical trial recruitment: Lessons from a South African site, Open Access Journal of Clinical Trials. mai, p.83, 2010.

A. Smith, Social Media Use, Pew Research Center, 2018.

M. S. Sedrak, Cancer Communication in the Social Media Age, JAMA Oncology. 1 juin, vol.2, issue.6, p.822, 2016.

R. Gossen, Social Media for Patient Recruitment: 6 Key Factors in Mayo Clinic's Success

R. Interactive, , 2011.

L. Gelinas, Using Social Media as a Research Recruitment Tool: Ethical Issues and Recommendations, The American Journal of Bioethics. 4 mars, vol.17, issue.3, pp.3-14, 2017.

C. Group, What is the HITECH ACT? | What HITECH Compliance Means

C. Group, , p.16, 2018.

D. Sur,

, EUGDPR -Information Portal [Internet]. [cité 30 déc, 2018.

, As Asia tightens up on data regulation, the EU GDPR leaves its footprint

D. Myshko, Accurately Costing a Clinical Trial. Pharma Voice. juil, p.9, 2005.

P. Bower, Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities, Trials. déc, vol.15, issue.1, 2014.

, Téléconsultation et téléexpertise : guide de bonnes pratiques

H. Autorité-de-santé,

, Virtual Clinical Trials -Can Remote Trials Change The Clinical Trial Landscape?

. Xtalks, , 2018.

D. Sur,

N. Ammour, From recruiting to data collection, the impact of connected digital health in clinical trials Practical Example : The VERKKO study, vol.18, 2016.

, Quand les essais cliniques plongent dans le virtuel

L. Echos, , 2018.

D. Sur,